ARIX BIOSCIENCE PLC
A liquidating venture capital company focused on biotech and life sciences.
ARIX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BD045071
- LEI:
- 213800OVT3AHQCXNIX43
- Country:
- United Kingdom
- Address:
- 1 More London Place, SE1 2AF London
- Website:
- https://www.arixbioscience.com/
Description
Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-12 14:02 |
Arix Bioscience Plc - Results of 2nd General Meeting
|
English | 123.9 KB | ||
| 2024-02-12 13:00 |
Scheme Effective
|
English | 28.0 KB | ||
| 2024-02-12 08:00 |
Suspension of Trading in Shares
|
English | 19.2 KB | ||
| 2024-02-07 12:30 |
Transaction Update
|
English | 30.8 KB | ||
| 2024-01-29 14:06 |
Arix Bioscience Plc - Results of 1st General Meeting
|
English | 61.5 KB | ||
| 2024-01-29 13:15 |
Results of First General Meeting
|
English | 28.6 KB | ||
| 2024-01-24 18:30 |
Holding(s) in Company
|
English | 66.9 KB | ||
| 2024-01-23 11:42 |
Arix Bioscience Plc - Circular and Notice of Second General Meeting
|
English | 138.5 KB | ||
| 2024-01-23 08:00 |
Update on the Scheme and Publication of Notice of Second General Meeting
|
English | 39.2 KB | ||
| 2024-01-22 08:00 |
Update on the Scheme and Resignation of Directors
|
English | 22.4 KB | ||
| 2024-01-19 08:01 |
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
|
English | 11.7 KB | ||
| 2024-01-19 08:00 |
Unaudited NAV for December 2023
|
English | 15.1 KB | ||
| 2024-01-08 18:15 |
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
|
English | 58.4 KB | ||
| 2024-01-05 08:00 |
Publication of Circular and RTW Bio Prospectus
|
English | 43.5 KB | ||
| 2024-01-04 18:30 |
Holding(s) in Company
|
English | 66.4 KB |
Automate Your Workflow. Get a real-time feed of all ARIX BIOSCIENCE PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ARIX BIOSCIENCE PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ARIX BIOSCIENCE PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
